Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Journal of Neurochemistry|May 19, 2010
Gi protein coupling to adenosine A1-A2A receptor heteromers in human brain caudate nucleusVicent Casadó, Sergio Barrondo, Milena Spasic, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 24, 2016
Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependenceGuadalupe Rivero, Idoia Martín-Guerrero, Elena de Prado, et al.
Journal of Pharmacological Sciences|April 27, 2025
Receptor-mediated Gi-3 activation in mammalian and human brain membranes: Reestablishment method and its application to nociceptin/orphanin FQ opioid peptide (NOP) receptor/Gi-3 interactionYuji Odagaki, Masakazu Kinoshita, Makoto Honda, et al.
European Journal of Medicinal Chemistry|November 3, 2020
Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activityMichela McMullan, Brendan Kelly, Helene B Mihigo, et al.
Bioorganic & Medicinal Chemistry|January 30, 2002
Long-acting fentanyl analogues: synthesis and pharmacology of N-(1-phenylpyrazolyl)-N-(1-phenylalkyl-4-piperidyl)propanamidesNadine Jagerovic, Carolina Cano, José Elguero, et al.
Elife|April 22, 2024
Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophreniaBohan Zhu, Richard I Ainsworth, Zengmiao Wang, et al.
Addiction Biology|August 4, 2020
Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-FubinacaJosé F Oliveira da Cruz, Christina Ioannidou, Antonio C Pagano Zottola, et al.
Plos One|July 9, 2020
Calcium-binding proteins are altered in the cerebellum in schizophreniaFrancisco Vidal-Domènech, Gemma Riquelme, Raquel Pinacho, et al.
Biomolecules|February 25, 2023
The Matricellular Protein Hevin Is Involved in Alcohol Use DisorderAmaia Nuñez-delMoral, Paula C Bianchi, Iria Brocos-Mosquera, et al.
Psychopharmacology|August 5, 2009
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatmentLeyre Urigüen, M Julia García-Fuster, Luis F Callado, et al.
Pageof 13